comparemela.com

Latest Breaking News On - Angel alberich bayarri - Page 1 : comparemela.com

Quibim and Merck to develop next wave of imaging-based diagnostics for precision medicine

Quibim and Merck to develop next wave of imaging-based diagnostics for precision medicine
businessweekly.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessweekly.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomAngel alberich bayarriMerck kgaDrug administrationUs health insurance portabilityMerck kgaaEuropean unionLife scienceGlobal cancer observatoryData protection regulationInsurance portability

Quibim and Merck to develop next wave of imaging-based diagnostics for precision medicine | Business Weekly | Technology News | Business news

Quibim and Merck to develop next wave of imaging-based diagnostics for precision medicine | Business Weekly | Technology News | Business news
businessweekly.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessweekly.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomMerck kgaAngel alberich bayarriMerck kgaaEuropean unionDrug administrationUs health insurance portabilityScience parkLife scienceGlobal cancer observatoryData protection regulationInsurance portability

Partnership to enhance efficiency of development for cancer medicine

Announced today (January 25), Quibim, a company transforming imaging data into actionable predictions of cancer progression and treatment responses, has partnered with Merck KGaA.

Angel alberich bayarriMerck kgaaMerck kgaGlobal cancer observatoryMarkets amp regulationsPreclinical researchClinical developmentContract manufacturing amp logisticsMergers and acquisitionsAtient centricityContract manufacturingData managementImmune systemClinical trials

Quibim Adds Cancer Detection Capability to Prostate AI Product

Quibim announced it has added an industry-leading cancer detection capability to its prostate tool based on artificial intelligence (AI). The updated product, QP-Prostate, which uses algorithms trained on actual pathology data as ground truth, has been given a CE mark for the European Union and a UKCA mark for the United Kingdom.

United kingdomDavid bazagaAngel alberich bayarriCancer research united kingdomEuropean unionWorld cancer research fund internationalMedical devicesNew yorkUnited states

Quibim s AI-based Early-stage Neurological Disease Quantification Software for Quantification of Early Brain Atrophy and Lesions Authorized for Use in US, EU and UK

Product significantly improves patient outcomes by enabling earlier diagnosis

United kingdomAngel alberich bayarriUs health insurance portabilityEuropean unionDrug administrationPrecision medicineData protection regulationInsurance portabilityAccountability act

vimarsana © 2020. All Rights Reserved.